THE BREAST IN THIS ISSUE BREAST CANCER SURVIVAL AND INCIDENCE OF SECOND PRIMARY CANCERS AFTER 30 YEARS IN A RANDOMIZED STUDY OF TWO VERSUS FIVE YEARS OF ADJUVANT TAMOXIFEN THERAPY 30 YEAR-BREAST CANCER SURVIVAL AND SECOND PRIMARY CANCERS AFTER ADJUVANT TAMOXIFEN ISSN 0960 9776 Volume 71 October 2023 An Official Journal of the European Society for Medical Oncology Official Journal of the Breast Centres Network Official Journal of the Hong Kong Breast Oncology Group Affiliated with the European Society of Breast Cancer Specialists An Associate Journal of the Australasian Society for Breast Disease IN THIS SUPPLEMENT ABSTRACT BOOK OF THE ADVANCED BREAST CANCER SEVENTH INTERNATIONAL CONSENSUS CONFERENCE (abc7) Volume 71 Supplement 1 October 2023
ABSTRACT BOOK ABC7 Advanced Breast Cancer Seventh International Consensus Conference 9-11 November 2023 Lisbon, Portugal Chair: F. Cardoso, PT Honorary Chairs: E.P. Winer, US - L. Norton, US - A. Costa, IT/CH Co-Chair: E. Schumacher-Wulf, DE Scientific Committee Members: S.X. Franco Millan, CO – K. Gelmon, CA J. Gligorov, FR – V. Mueller, DE B.V. Offersen, DK – S.M. Swain, US Bridging the Gap ABC7 will be followed by the meeting of the on 11-12 November 2023 ABC7 is being organised as hybrid meeting. The ABC7 guidelines will be developed by the Global Alliance The ABC7 guidelines are endorsed by The ABC7 conference is held with support from held under the auspices of endorsed by and held with official representatives of 2018 2018
THE BREAST Editor-in-Chief Fatima Cardoso, Champalimaud Clinical Centre, Lisbon, Portugal Co-Editors Nehmat Houssami, University of Sydney, Sydney, Australia Giuseppe Curigliano, University of Milano, European Institute of Oncology, Milan, Italy Specialty Editor E. Negri, Milan, Italy A. Tagliafico, Genova, Italy S. Delaloge, Paris, France F. Penault-Llorca, Clermont-Ferrand, France M.J. Cardoso, Lisbon, Portugal O. Gentilini, Milan, Italy E. Senkus-Konefka, Gdansk, Poland P. Poortmans, Paris, France S. Di Cosimo, Milan, Italy G. Pravettoni, Milan, Italy H. Rugo, San Fransisco, USA Epidemiology and Prevention: Imaging, Screening and Early Diagnosis: Familial and Hereditary Breast Cancer: Pathology: Surgery and Oncoplastic Surgery: Medical Oncology: Radiation Oncology: Translational Research: Psycho-oncology and Quality of Life and Survivorship: Social Media Editor: E. Elder, New South Wales, Australia C. Tinterri, Milan, Italy C. Markopoulos, Athens, Greece S. Delaloge, Paris, France B. Thürlimann, St Gallen, Switzerland Australasian Society for Breast Disease Representative Breast Centres Network Representative: European Society for Breast Cancer Specialists (EUSOMA) Representative European Society for Medical Oncology (ESMO) Representative St. Gallen Oncology Conferences Representative http://www.thebreastonline.com An associate journal of the Australasian Society for Breast Disease (ASBD), affiliated with the European Society of Breast Cancer Specialists (EUSOMA), the European Society for Medical Oncology (ESMO), and the official journal of Breast Centres Network (BCN) and the Hong Kong Breast Oncology Group (HKBOG). Amsterdam • Boston • London • New York • Oxford • Paris • Philadelphia • San Diego • St Louis International Advisory Board M.M Regan Boston, Massachusetts, USA I. Rubio Barcelona, Spain V. Sacchini New York, NY, USA K. Sandelin Stockholm, Sweden F. Sardanelli Milan, Italy G. Schwartsmann Porto Alegre, Brazil V. Semiglazov St. Petersburg, Russia V. Speirs Leeds, UK E. Tagliabue Milan, Italy A. Tagliafico Genova, Italy D.A. Vorobiof Johannesburg, S.A. M.G. Wallis Cambridge, UK N. Williams London, UK B. Xu Beijing, China Y. Yarden Tel Aviv, Israel S. Zackrisson Malmö, Sweden J. Zˇgajnar Ljubljana, Slovenia B. Anderson Seattle, USA B. Arun Houston, Texas, USA H.A. Azim Marseille, France G. de Bock Groningen, The Netherlands J. Bogaerts Brussels, Belgium E. Brain Saint-Cloud, France M. Brennan Sydney, Australia R.E. Coleman Sheffield, UK J. Cortes Barcelona, Spain A. Costa Milan, Italy T. Cufer Ljubljana, Slovenia R. Dent Prato, Italy V. Diéras, MD Rennes, France J. M. Dixon Edinburgh, Scotland S. Duffy London, UK L.E.M. Duijm Nijmegen, Netherlands N. El Saghir Beirut, Lebanon W. Gatzemeier Milan, Italy J.Gligorov Paris, France S. Hurvitz Santa Monica, USA S.-A. Im Seoul, Republic of Korea G. Jerusalem Liège, Belgium S.-B. Kim Seoul, Republic of Korea H. de Koning Eindhoven, The Netherlands S. Kyriakides Nicosia, Cyprus B. Linderholm Gothenburg, Sweden L. Lusa Ljubljana, Slovenia B. Mann Parkville, Australia L. Marinovich Bentley, Australia S. Nakamura Tokyo, Japan S. Ohno Fukuoka, Japan M. Paesmans Brussels, Belgium A. Partridge Boston, USA F.A Peccatori Milan, Italy K. Pritchard Toronto, Canada
VOLUME 71 SUPPLEMENT 1 October 2023 Advanced Breast Cancer Seventh International Consensus Conference (ABC7) Welcome S1 General Information S2 High Patronage S4 Endorsement and Auspices S4 Sponsors S5 ABCAward S6 ABC7 Scientific Committee S6 Breast Cancer Patient Advocacy Programme S8 Programme S9 Consensus Panellists S13 Sponsored satellite symposia S14 Abstract Presenters S15 Poster Session S17 Invited Abstracts S19 Abstracts – Nursing and Advocacy S28 Abstracts – Basic and Translational Research S44 Abstracts – Clinical Issues: Medical Oncology S47 Abstracts – Clinical Issues: Radiation Oncology S61 Abstracts – Clinical Issues: Surgical Oncology S63 Abstracts – Clinical Issues: Supportive and Palliative Care S64 Abstracts – Clinical Issues: Other Topics S69 Disclosure of Conflict of Interest S72 Authors Index S75 Abstract List S78 Publication of this Abstract Book is supported by the ABC Global Alliance. Guide for Authors Submission toTheBreast proceeds totally online via the Elsevier Editorial System page of this journal at http://ees.elsevier.com/thebreast/. Authors will be guided through the creation and uploading of the various files. Once the uploading is done, the system automatically generates an electronic (PDF) proof, which is then used for reviewing. All correspondence, including the Editor’s decision and request for revisions, will be by e-mail. Authors may send queries concerning the submission process, manuscript status, or journal procedures to the editorial office at thebreast@elsevier.com Available online at www.sciencedirect.com Indexed/abstracted in: Index Medicus, MEDLINE, ABI/Inform, Current Awareness in Biological Sciences, Current Contents/Clinical Medicine, EMBASE, Excerpta Medica National Library of Medicine (MEDLARS and MEDLINE), Research Alert, SCISEARCH, Science Citation Index, Scopus Amsterdam• Boston • London • NewYork • Oxford • Paris • Philadelphia • SanDiego • St Louis
The Breast: Aims and Scope The Breast is a multidisciplinary journal for researchers and clinicians, which focuses on translational and clinical research for the advancement of breast cancer prevention, diagnosis and treatment of all stages. The Editors welcome the submission of original research articles, systematic reviews, and viewpoint/commentary and debate articles, and correspondence on all areas of pre-malignant and malignant breast disease, including: • Epidemiology and prevention • Translational research, encompassing the use of new technologies, molecular biology, genetics and pathology • Screening, early diagnosis, follow-up and response assessment: use of imaging, nuclear medicine and other technologies • Medical oncology • Radiation oncology • Breast surgery • Psycho-oncology • Quality of life • Survivorship • Supportive care • Palliative and end-of-life care • Advocacy • Breast nursing • Breast units management and organization of breast care, including health economics. Author enquiries You can track your submitted article at http://www.elsevier.com/track-submission. You can track your accepted article at http://www.elsevier.com/trackarticle. You are also welcome to contact Customer Support via http://support. elsevier.com. Publication information. The Breast (ISSN 0960-9776). For 2023, volumes 67–72 (6 issues) are scheduled for publication. Further information is available on this journal and other Elsevier products through Elsevier’s website: (http:// www.elsevier.com). Subscriptions are accepted on a prepaid basis only and are entered on a calendar year basis. Issues are sent by standard mail (surface within Europe, air delivery outside Europe). Priority rates are available upon request. Claims for missing issues should be made within six months of the date of dispatch. Orders, claims, and journal inquiries: Please visit our Support Hub page https://service.elsevier.com for assistance. USA mailing notice: The Breast (ISSN 0960-9776) is published bimonthly by Elsevier Ltd. (P.O. Box 211, 1000 AE Amsterdam, The Netherlands). Periodicals postage paid at Jamaica, NY 11431 and additional mailing offices. USA POSTMASTER: Send address changes to The Breast, Elsevier, Journal Returns, 1799 Highway 50 East, Linn, MO 65051, USA. AIRFREIGHT AND MAILING in USA by Air Business Ltd., c/o Worldnet Shipping Inc., 156-15, 146th Avenue, 2nd Floor, Jamaica, NY 11434, USA. Copyright © 2023 Elsevier Ltd. All rights reserved. This journal and the individual contributions contained in it are protected under copyright, and the following terms and conditions apply to their use in addition to the terms of any Creative Commons or other user license that has been applied by the publisher to an individual article: Photocopying Single photocopies of single articles may be made for personal use as allowed by national copyright laws. Permission is not required for photocopying of articles published under the CC BY license nor for photocopying for noncommercial purposes in accordance with any other user license applied by the publisher. Permission of the publisher and payment of a fee is required for all other photocopying, including multiple or systematic copying, copying for advertising or promotional purposes, resale, and all forms of document delivery. Special rates are available for educational institutions that wish to make photocopies for non-profit educational classroom use. Derivative Works Users may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions or companies. Other than for articles published under the CC BY license, permission of the publisher is required for resale or distribution outside the subscribing institution or company. For any subscribed articles or articles published under a CC BY-NC-ND license, permission of the publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Except as outlined above or as set out in the relevant user license, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the publisher. Permissions For information on how to seek permission visit www.elsevier.com/permissions Author rights Author(s) may have additional rights in their articles as set out in their agreement with the publisher (more information at http://www.elsevier.com/authorsrights). Notice Practitioners and researchers must always rely on their own experience and knowledge in evaluating and using any information, methods, compounds or experiments described herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. To the fullest extent of the law, no responsibility is assumed by the publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer. Language (usage and editing services) Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier’s WebShop http://webshop.elsevier.com/languageediting/ or visit our customer support site http://support.elsevier.com for more information. Illustration services Elsevier’s WebShop (http://webshop.elsevier.com/illustrationservices) offers Illustration Services to authors preparing to submit a manuscript but concerned about the quality of the images accompanying their article. Elsevier’s expert illustrators can produce scientific, technical and medical-style images, as well as a full range of charts, tables and graphs. Image ‘polishing’ is also available, where our illustrators take your image(s) and improve them to a professional standard. Please visit the website to find out more. ∞ The paper used in this publication meets the requirements of ANSI/NISO Z39.48-1992 (Permanence of Paper). Printed in the United Kingdom by Henry Ling Limited, at the Dorset Press, Dorchester, DT1 1HD. The Breast has no page charges.
More time with the people we love. Our work gives people more time with their loved ones. And for over 125 years, it’s what always drives us to continue to innovate. We put healthcare’s unsolved challenges at the heart of our business because it’s where we can make the biggest difference. www.roche.com Document number: M-XX-00014952 Date of preparation: September 2023 M-PT-00002195 Setembro 2023
HYBRID MEETING | 9-11 November 2023 • ABC7 21
Welcome Dear Colleagues, It is with great pleasure that I invite you to join us at the Advanced Breast Cancer Seventh International Consensus Conference (ABC 7) that will take place in Lisbon, Portugal, on 9–11 November 2023. The ABC Consensus Conference has established itself as the major international conference for advanced breast cancer. Its uniqueness resides in the central role of ABC patients and in its truly global reach. We strongly believe that health professionals working closely together with patients and advocates and with the strong support of the media can raise awareness and effectively lobby in favor of this previously underserved and often forgotten group of patients. The conference's primary goal is the development of international consensus guidelines for the management of advanced breast cancer. These guidelines are based on the most up-to date evidence and can be used to guide treatment decision-making in a wide variety of different health care settings globally, with the necessary adaptations due to different access to care. Throughout the years, these guidelines have been endorsed by several international organizations, and many organizations around the world have been adapting them to their country specific environment, particularly in terms of promoting accessibility both to health care services and new therapeutic agents. ABC also aims to be a forum to analyze and discuss the latest scientific updates in the field, to identify research priorities and important areas of unmet needs, as well as influence policy makers, regulatory and funding bodies and ultimately improve standards of care, survival and quality of life for all patients living with ABC worldwide. The ABC consensus conference started from the desire to address and change the sense of abandonment and invisibility experienced by many patients with ABC patients and the urgent need to change their outcomes. In 2011 the European School of Oncology pioneered this initiative and today the conference has evolved and, is organized by the ABC Global Alliance. The ABC Global Alliance is an independent non-profit multistakeholder organization dedicated exclusively to improve and extend the lives of women and men living with ABC worldwide, and currently has more than 200 members in over 90 countries worldwide. Due to the COVID-19 pandemic, our last meeting (ABC 6) was held virtually and brought together around 1.000 participants from 67 countries around the world, including health professionals, patients, advocates, and journalists. Fortunately, this year, we will be able to meet again face-to-face and enjoy the powerful and passionate interactions among attendees. All topics will be presented from the perspective of a multidisciplinary approach, from basic research through to clinical implementation. The conference will again close with a consensus session aimed at updating the ABC guidelines. It is my pleasure to invite you to join us in Lisbon for the 7th edition of the Advanced Breast Cancer International Consensus Conference (ABC7), and to work with us to improve the lives of all ABC patients. Fatima Cardoso, MD Chair of ABC7 and President of the ABC Global Alliance The Breast 71S1 (2023) S1 Contents lists available at ScienceDirect The Breast journal homepage: www.journals.elsevier.com/the-breast 0960-9776/© 2023 Elsevier Ltd. All rights reserved.
General Information Conference dates Platform, On-demand sessions, ePosters: 30 October 2023 to 30 April 2024 Live sessions: 9–10 November 2023 Consensus sessions: 11 November 2023 Venue ABC7 will take place as an onsite event in Lisbon, 9–11 November 2023, at the CCL - Centro de Congressos de Lisboa, Praça das Industrias, Lisbon, Portugal as well as online, through a dedicated virtual platform. Official Carrier The ABC Global Alliance is grateful to TAP Portugal, a Star Alliance member, who supported the Conference as the Official Carrier and offered discounted fares to the participants. Acknowledgements The ABC Global Alliance wishes to express its appreciation and gratitude to the ABC7 Chair, Honorary Chairs for their support and vision in establishing this conference, Co-Chair, all Scientific Committee Members, all Breast Cancer Patient Advocacy Committee members, faculty and panellists for their commitment and contribution to the programme, to The Breast and CancerWorld for their partnership in this initiative. Organisational Team Organization Roberta Ventura (1) Programme rventura@abcglobalalliance.org Exhibition, satellite symposia and sponsorship ABCAward Paulina Gono (1) Marketing, communication and social media pgono@ abcglobalalliance.org Travel grants Abstracts Dolores Knupfer (1) Accreditation abc7@abcglobalalliance.org Accommodation, tours Helder Carvalho (2) registration helder.carvalho@abreu.pt 1 ABC Global Alliance c/o Fundação Champalimaud, Avenida de Brasília s/n 1400-038 Lisboa, Portugal 2 Viagens Abreu SA Av. 25 de Abril, 2 2799-556 Linda-a-Velha, Portugal CME accreditation and certificates Participants will be entitled to receive a certificate of attendance at the close of the conference by completing the evaluation questionnaire. Applications for CME recognition were submitted to the Accreditation Council of Oncology in Europe (ACOE) and the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS). The Breast 71S1 (2023) S2–S3 Contents lists available at ScienceDirect The Breast journal homepage: www.journals.elsevier.com/the-breast 0960-9776/© 2023 Elsevier Ltd. All rights reserved.
Social media Post, network and follow updates using #ABClisbonon X, LinkedIn and Facebook. @ABCGlobalAll @ABC-Global-Alliance Third party media policy The policy applies to all activities related to the news media during or in connection with ABC7 and is posted at www.abc-lisbon.org. The aim is to ensure that information distributed to the journalists is accurate and is issued at the correct times, complying with any embargoes that may be in place. The policy applies to media events that are organised in connection with ABC7 and all third parties are requested to adhere to it. GRASP Poster Walkthroughs The ABC Global Alliance is pleased to collaborate with GRASP - Guiding Researchers and Advocates to Scientific Partnerships - to offer their engaging and informative Poster Walkthroughs at ABC7. Abstract Book This book includes abstracts submitted by the invited speakers and those proposed by the participants that were accepted for oral presentation, e-poster presentation or publication. Abstracts were received for seven categories: • Advanced breast cancer – Nursing and advocacy • Advanced breast cancer – Basic and translational research • Advanced breast cancer – Clinical issues: Medical oncology • Advanced breast cancer – Clinical issues: Radiation oncology • Advanced breast cancer – Clinical issues: Surgical oncology • Advanced breast cancer – Clinical issues: Supportive and palliative care • Advanced breast cancer – Clinical issues: Other topics A prefix has been added to the abstract number to identify the type of presentation or acceptance: IN: Abstracts submitted by the invited speakers OR: Abstracts accepted for oral presentations BP: Abstracts accepted as best poster and e-best poster presentations PO: Abstracts accepted for poster and e-poster presentations PR: Abstracts accepted for inclusion in the abstract book (not presented at the conference) The Accreditation Council of Oncology in Europe (ACOE) has awarded 15 credits to the conference. The event is further designated for a maximum of 15.5 CME credits (ECMEC). Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits™. General Information / The Breast 71S1 (2023) S2–S3 S3
High Patronage The ABC Global Alliance is proud to announce that the Conference is held under the High Patronage of His Excellency the President of the Portuguese Republic, Prof. Marcelo Rebelo de Sousa. The ABC Global Alliance is proud to announce that the Conference is held under the Patronage of the European Parliament. Endorsement and Auspices The Breast 71S1 (2023) S4 Contents lists available at ScienceDirect The Breast journal homepage: www.journals.elsevier.com/the-breast 0960-9776/© 2023 Elsevier Ltd. All rights reserved.
Sponsors The ABC Global Alliance wishes to express its appreciation for the following sponsors for having granted their participation and support toABC7. Travel grants, support to the conference and to the patient advocacy activities Participating organizations (as of 25 October 2023) Participating companies (as of 25 October 2023) A Menarini Group Company The Breast 71S1 (2023) S5 Contents lists available at ScienceDirect The Breast journal homepage: www.journals.elsevier.com/the-breast 0960-9776/© 2023 Elsevier Ltd. All rights reserved.
ABCAward The ABC Award is aimed at recognizing a researcher, physician, nurse or patient advocate who has made an outstanding and impactful contribution in the field of advanced breast cancer throughout his/her cancer career. The 2023 ABC Award – in recognition of her tireless work to improve the care of breast cancer patients, and metastatic breast cancer patients in particular, around the world, with an expertise in navigation, survivorship, patient-centred care, quality of life, end of-life planning and care (with emphasis on the powerful MBC Retreats), improving the cancer patient's experience and clinical outcomes, but also as public speaker and author of many books – will be assigned to Lillie Shockney during the award session on Thursday, 9 November. The 2021 ABC Award- in recognition of her outstanding advocacy work for all ABC patients worldwide, accomplished through the Metastatic Breast Cancer Network, the Metastatic Breast Cancer Alliance and more recently the Advanced Breast Cancer Global Alliance - was assigned toShirley A. Mertz. The 2019 ABC Award - in recognition of her foresight in understanding the importance of advanced breast cancer and for launching a Global Alliance against it - was assigned to Fatima Cardoso. The2017 ABC Award- in recognition for her work and dedication to advocacy specifically to advanced breast cancer patients - was assigned toMusaMayer. The 2015 ABC Award - in recognition for his work on metastatic breast cancer, especially improving the management of metastatic cancer to bone, resulting in preservation and improvement in quality of life of patients worldwide - was assigned to Robert E. Coleman. The 2013 ABC Award - in recognition of his work on discovering fundamental, clinically-relevant biological and molecular mechanisms for metastases including site specificity, latency, self-seeding and the role of the microenvironment in colonization and drug resistance - was assigned toJoan Massagué. ABC7 Scientific Committee Chair Fatima Cardoso, Breast Unit, Champalimaud Clinical Center, Lisbon, PT Honorary Chairs Eric P. Winer, Breast Oncology Center, Dana-Farber Cancer Institute, Boston, US Larry Norton, Breast Cancer Programs, Memorial Sloan-Kettering Cancer Centre, New York, US Alberto Costa, European School of Oncology, Milan, IT and Bellinzona, CH Co-Chair Eva Schumacher-Wulf, Mamma Mia, Kronberg, DE Scientific Committee Members Sandra Ximena Franco Millan, Cancer Treatment and Research Center Bogota, CO Karen Gelmon, BC Cancer Agency, Department of Medical Oncology, Vancouver, CA Joseph Gligorov, Department of Medical Oncology, Cancer Est APHP Tenon, University Paris VI, Paris, FR Volkmar Mueller, University Medical Center, Hamburg-Eppendorf, Hamburg, DE Birgitte V. Offersen, Department of Oncology, Aarhus University Hospital, DK Sandra M. Swain, Georgetown University Medical Center and MedStar Health, Washington DC, US Faculty Members Matti S. Aapro, IMO Clinique de Genolier, Institut Multidisciplinare d'Oncologie, Genolier, CH Isabelle Aloi-Timeus, Salvati Foundation AC, Mexico City, MX Jyoti Bajpai, Tata Memorial Centre, HBNI, Mumbai, IN Sarah-Jane Barker, Healthcare communications lead and ABC caregiver, London, UK Carlos H. Barrios, Department of Medicine, PUCRS School of Medicine, Porto Alegre, BR Elizabeth Bergsten-Nordström, Europa Donna - The European Breast Cancer Coalition, SE Laura Biganzoli, Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, IT Maria João Cardoso, Breast Unit, Champalimaud Cancer Center and MamaHelp, Lisbon, PT Lisa A. Carey, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, US Mariana Chavez Mac Gregor, Health Services Research Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, US Runcie C.W. Chidebe, Project Pink Blue, Abuja, NG Charlotte Coles, University of Cambridge, UK Javier Cortés, International Breast Cancer Center (IBCC), Madrid and Barcelona, ES Lioe-Fee de Geus, University of Leiden, NL Rebecca A. Dent, National Cancer Center Singapore, Singapore, SG Andre Dourado, Mama Help - Breast Cancer Support Center, Porto, PT Amanda Drury, Dublin City University, Dublin, IE Vicky Durston, Breast Cancer Network Australia, Camberwell, AU The Breast 71S1 (2023) S6–S7 Contents lists available at ScienceDirect The Breast journal homepage: www.journals.elsevier.com/the-breast 0960-9776/© 2023 Elsevier Ltd. All rights reserved.
Nagi S. El Saghir, NK Basile Cancer Institute American University of Beirut Medical Center Beirut, LB Alexandru Eniu, Hopital Riviera-Chablais, Vaud-Valais, Rennaz, CH Lesley Fallowfield, Brighton & Sussex Medical School, University of Sussex, Brighton, UK Prudence A. Francis, Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, AU Jenny Gilchrist, The McGrath Foundation, St. Leonards, AU William J. Gradishar, Northwestern Medicine, Illinois, US Bishal Gyawali, Queen's University, Division of Cancer Care and Epidemiology, Kingston, CA Renate Haidinger, Brustkrebs Deutschland e.V., Munich, DE Nadia Harbeck, Breast Centre, University of Munich, Munich, DE XichunHu, Fudan University Shanghai Cancer Center, Shanghai, CN André Ilbawi, World Health Organization, Geneva, CH Dimitris Kalogeropoulos, Global Health & Digital Innovation Foundation, London, UK Ranjit Kaur, Breast Cancer Welfare Association, Pataling Jaya, MY Belinda Kiely, NHMRC Clinical Trials Centre, Sydney Medical School, Sydney, AU Sung-Bae Kim, Asan Medical Centre, Department of Oncology, Seoul, KR Marion Kuper-Hommel, Waikato Hospital, Midland Regional Cancer Centre, Hamilton, NZ Stella Kyriakides, European Commissioner for Health and Food Safety, Brussels, BE Frédéric E. Lecouvet, Dept of Radiology, Centre du Cancer and Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, BE Matteo Lambertini, IRCCS Ospedale Policlinico San Martino, University of Genoa, IT Nanre Mampak, National Hospital Abuja, NG and University of Rwanda, RW Ginny Mason, Inflammatory Breast Cancer Research Foundation, West Lafayette, US Leonor Matos, Champalimaud Clinical Center, Lisbon, PT Claire Myerson, Breast Cancer Now, London, UK Shirley A. Mertz, MBC US Alliance and Metastatic Breast Cancer Network US, Inverness, US Gertrude Nakigudde Uganda Women's Cancer Support Organisation, Kampala, UG Silvia Neciosup, Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, PE Shinji Ohno, Breast Oncology Centre, Cancer Institute Hospital, Tokyo, JP Shani Paluch-Shimon, Hadassah University Hospital - Sharett Institute of Oncology Jerusalem, IL Ann H. Partridge, Dana-Farber Cancer Institute, Breast Oncology Dpt. and Adult Survivorship Programme, Boston, US Frédérique Penault-Llorca, Jean Perrin Centre, Comprehensive Cancer Centre, Clermont-Ferrand, FR Hope S. Rugo, Breast Oncology and Clinical Trials Education UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, US Elzbieta Senkus, Medical University of Gdansk, Gdansk, PL Lillie Shockney, Johns Hopkins University School of Medicine, Baltimore, US Andrea Smith, Breast Cancer Network Australia, Camberwell, AU Richard Sullivan, King's College London, UK Nicholas Turner, Institute of Cancer Research, London, UK Galina Velikova, University of Leeds, UK Peter Vuylsteke, University of Botswana, Gaborone, BW Theresa Wiseman, The Royal Marsden NHS Foundation Trust, University of Southampton, UK Rachel Würstlein, Breast Center and CCC Munich, LMU University Munich, DE Marzia Zambon, Europa Donna - The European Breast Cancer Coalition, Milan, IT ABC7 Scientific Committee / The Breast 71S1 (2023) S6–S7 S7
Breast Cancer Patient Advocacy Programme Representatives of breast cancer patient advocacy groups are warmly invited to participate in ABC7 and actively contribute to the scientific programme and consensus session. Breast Cancer Patient Advocacy Committee Coordinator: Fatima Cardoso, ABC Global Alliance, Lisbon, PT Bertha Aguilar Lopez, MILC Foundation, Mexico City, MX Elizabeth Bergsten-Nordström, Europa Donna - The European Breast Cancer Coalition, SE Maria João Cardoso, MamaHelp Association, Lisbon, PT Runcie C.W. Chidebe, Project Pink Blue, Abuja, NG Renate Haidinger, Brustkrebs Deutschland e.V., Munich, DE Ranjit Kaur, Breast Cancer Welfare Association, Pataling Jaya, MY Ginny Mason, Inflammatory Breast Cancer Research Foundation, West Lafayette, US Shirley A. Mertz, MBC US Alliance and Metastatic Breast Cancer Network US, Inverness, US Claire Myerson, Breast Cancer Now, London, UK Gertrude Nakigudde, Uganda Women's Cancer Support Organisation, Kampala, UG Kim Sabelko, Susan G. Komen, Washington, US Eva Schumacher-Wulf, Mamma Mia, Kronberg, DE Andrea Smith, Breast Cancer Network Australia, Camberwell, AU The Breast 71S1 (2023) S8 Contents lists available at ScienceDirect The Breast journal homepage: www.journals.elsevier.com/the-breast 0960-9776/© 2023 Elsevier Ltd. All rights reserved.
Programme The conference will be organized in a hybrid format. Live streaming will be available for online participants. Thursday, 9 November 2023 9:00-10:30 Audit. I Patient advocacy session: Beyond my cancer treatments: What else? Chairs: Maria Joao Cardoso, PT and Renate Haidinger, DE 9:00-9:10 Over the counter in advanced breast cancer. Fears and questions? Maria Joao Cardoso, PT and Renate Haidinger, DE 9:10-9:30 Integrative medicine in advanced breast cancer treatment. The actual panorama (abstract IN3). Rachel Würstlein, DE 9:30-9:50 The medical oncologist needs. How to deal with no information Silvia Neciosup, PE 9:50-10:10 What else besides the cancer medication. What is good and what is bad. The interactions André Dourado, PT 10:10-10:30 Discussion All 10:30-11:00 Coffee break 11:00-12:30 Audit. I Patient advocacy session: Complexities of shared decision making Chairs: Elizabeth Bergsten-Nordström, SE - Ginny Mason, US - Eva SchumacherWulf, DE 11:00-11:10 Introduction Elizabeth Bergsten-Nordström, SE - Ginny Mason, US 11:10-11:25 How mental health issues influence shared decision-making Lesley Fallowfield, UK 11:25-11:45 How to discuss survival times and be prepared for end-of-life care decisions Belinda Kiely, AU 11:45-12:00 Overcoming my fears and being prepared Claire Myerson, UK 12:00-12:30 Discussion All 12:30-13:30 Lunch 13:30-15:10 Audit. I Opening session Chairs: Fatima Cardoso, PT and Larry Norton, US 13:30-13:45 Welcome to Lisbon Carlos Moedas, Mayor of Lisbon, PT 13:45-13:55 Welcome message from Stella Kyriakides, European Commissioner for Health and Food Safety, on Europe’s Beating Cancer Plan and breast cancer Stella Kyriakides, European Commissioner for Health and Food Safety, BE 13:55-14:10 Welcome to ABC7 Fatima Cardoso, PT 14:10-14:40 Keynote lecture: From daughter to decision maker: The shifting role of a caregiver in metastatic breast cancer Sarah-Jane Barker, UK 14:40-15:10 ABC7 Award lecture: The spark that lit the fire–My journeys with ABC patients and their families (abstract IN1) Lillie Shockney, US 15:10-15:50 Audit. I Best Abstract presentations Chairs: Eva Schumacher-Wulf, DE and Eric P. Winer, US 15:10-15:20 Updated overall survival (OS) outcomes from the phase 3 PHOEBE trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer (abstract OR98) Xichun Hu, CN 0960-9776/© 2023 Elsevier Ltd. All rights reserved. The Breast 71S1 (2023) S9–S12 Contents lists available at ScienceDirect The Breast journal homepage: www.journals.elsevier.com/the-breast
15:20-15:30 Enhancing patient care: interim data analysis and patient experience of personalized electronic symptom monitoring led by a specialist nurse for engagement in treatment and improved quality of life in advanced breast cancer (abstract OR139) Marion Kuper-Hommel, NZ 15:30-15:40 The impact on productivity costs of reducing unemployment in patients with advanced breast cancer: A model estimation based on a Portuguese nationwide observational study (abstract OR46) Leonor Matos, PT 15:40-15:50 Discussion All 15:50-16:20 Coffee break 16:20-18:00 Audit. I Clinical Dilemmas Chairs: Claire Myerson, UK and Sandra Swain, US 16:20-16:40 Impact of new early breast cancer standards in the choice of first line therapies (abstract IN10) Mariana Chavez MacGregor, US 16:40-16:55 How to optimize care for long term responders: to be or not to be on "treatment holidays" (abstract IN11) Joseph Gligorov, FR 16:55-17:05 From DNR to ICU - expanding the rights of ABC patients (abstract IN12) Ann H. Partridge, US 17:05-17:20 New QoL tools for ABC: EU H2O project and EORTC / ABC Global Alliance tool Galina Velikova, UK 17:05-17:25 Discussion All 18:00-19:30 Audit. II Patient advocacy session: The central role of nursing for ABC patients Chairs: Andrea Smith, AU and Theresa Wiseman, UK 18:00-18:02 Welcome 18:02-18:12 What difference can nurses make to the care of patients with ABC? The perspective of patients and family members Andrea Smith, AU 18:12-18:32 The specialised metastatic breast care nurse role in Australia. The nurses' role in helping people manage side effects, treatment and emergencies Jenny Gilchrist, AU 18:32-18:52 Nursing support for ABC patients: perspective from low and middle-income countries Nanre Mampak, NG 18:52-19:12 Enabling nurses to provide appropriate care for patients with ABC: the development of a specialised training program for ABC nurses Amanda Drury, IE 19:12-19:30 Discussion Amanda Drury, IE - Vicky Durston, AU - Jenny Gilchrist, AU - Nanre Mampak, NG - Andrea Smith, AU - Theresa Wiseman, UK 18:00-19:30 Audit. I Sponsored satellite symposium: (details are available on page S14) 19:30 Welcome cocktail Friday, 10 November 2023 8:30-9:30 Audit. I Biology 1.0 Chairs: Mariana Chavez MacGregor, US and Alexandru Eniu, CH 8:30-8:45 Interpreting a NGS report (abstract IN18) Nadia Harbeck, DE 8:45-9:00 Interpreting a liquid biopsy report Nick Turner, UK 9:00-9:15 Interpreting a genetic test report Shani Paluch-Shimon, IL 9:15-9:30 Discussion All 9:30-10:45 Audit. I Biology 2.0 Chairs: Belinda Kiely, AU and Sung-Bae Kim, KR 9:30-09:45 Optimizing molecular subtypes classification William J. Gradishar, US 9:45-10:00 How low should we go? HER2 low, ER low Frédérique Penault-Llorca, FR 10:00-10:15 Redefining endocrine resistance (abstract IN23) Lisa A. Carey, US Programme / The Breast 71S1 (2023) S9–S12 S10
10:15-10:35 How can Artificial Intelligence help? (abstract IN24) Dimitris Kalogeropoulos, UK 10:35-10:45 Discussion All 10:45-11:15 Coffee break 11:15-12:15 Audit. I Loco-regional highlights Chairs: Marion Kuper-Hommel, NZ and Elzbieta Senkus, PL 11:15-11:30 When should the primary tumor be treated in ABC? (abstract IN25) Maria João Cardoso, PT 11:30-11:45 Leveraging concomitant radio-targeted therapy for MBC and inoperable LABC (abstract IN26) Birgitte V. Offersen, DK 11:45-12:00 Revisiting oligometastatic disease (abstract IN27) Prudence A. Francis, AU 12:00-12:15 Discussion All 12:15-13:00 Audit. I Improving Imaging of ABC Chairs: Jyoti Bajpai, IN, and William J. Gradishar, US 12:15-12:30 Optimal use of Pet-CT in ABC: new EANM-SNMMI guidelines (abstract IN28) Lioe-Fee de Geus, NL 12:30-12:45 New Imaging technologies and strategies in ABC (abstract IN29) Frédéric E. Lecouvet, BE 12:45-13:00 Discussion All 13.00-14:00 Lunch and poster session 14:00-15:30 Audit. I Tough Issues in ABC. Report from WebSeries Chairs: Matti S. Aapro, CH and Gertrude Nakigudde, UG 14:00-14:15 ABC in a pregnant patient (abstract IN30) Matteo Lambertini, IT 14:15-14:30 Optimal management of inflammatory inoperable LABC and/or MBC (abstract IN31) Karen Gelmon, CA 14:30-14:45 Optimal management of a patient with ABC in visceral crisis Hope S. Rugo, US 14:45-15:00 Management a patient with ABC and HIV (abstract IN33) Peter Vuylsteke, BW 15:00-15:15 Optimal management of an older frail patient with ABC Laura Biganzoli, IT 15:15-15:30 Management of leptomeningeal disease Volkmar Mueller, DE 15:30-15:50 Coffee break 15:50-17:05 Audit. I The perfect storm: war, recession, regulatory / payers' hurdles Chairs: Carlos H. Barrios, BR - Nagi El Saghir, LB - Marzia Zambon, IT 15:50-16:05 Caring for cancer patients amidst war Richard Sullivan, UK 16:05-16:20 Barriers and inequalities due to old fashion regulatory and / or recruitment rules (abstract IN37) Bishal Gyawali, CA 16:20-16:35 Will the WHO Global Breast Cancer Initiative (GBCI) help ABC patients? André Ilbawi, CH 16:35-16:50 The new Lancet Commission on BC: a powerful lobbying for ABC Charlotte Colés, UK 16:50-17:05 Discussion All 17:05-18:00 Audit. I News from ABC6 Chairs: Silvia Neciosup, PE and Shinji Ohno, JP 17:05-17:20 HER2+ (abstract IN40) Javier Cortés, ES 17:20-17:35 ER+ / Her2 Neg Sandra Franco, CO 17:35-17:50 Triple negative Rebecca A. Dent, SG 17:50-18:00 Discussion All 18:00-19:30 Audit. II Patient advocacy session: Rehabilitation to manage disabilities in metastatic breast cancer Chairs: Runcie C. W. Chidebe, NG and Ranjit Kaur, MY 18:00-18:10 Introduction Runcie C. W. Chidebe, NG and Ranjit Kaur,MY 18:10-18:30 My multiple burdens of living with MBC, disabilities, poor access to care and workplace issues. Shirley A. Mertz, US 18:30-18:50 Relationship between diet and exercise in MBC patients (abstract IN44) Leonor Matos, PT Programme / The Breast 71S1 (2023) S9–S12 S11
18:50-19:05 Managing Lymphoedema in MBC patients Isabelle Aloi-Timeus, MX 19:05-19:30 Discussion All 18:00-19:30 Audit. I Sponsored satellite symposium: (details are available on page S14) Saturday, 11 November 2023 8:30-10:30 Audit. I Consensus session(part I) ABC7 Chairs, Scientific Committee Members and Panelists 10:30-11:00 Coffee break 11:00-11:15 Audit. I Report from ABC Patient Advocacy Committee Renate Haidinger, DE 11:15-12:45 Audit. I Consensus session(part II) ABC7 Chairs, Scientific Committee Members and Panelists 12:45-13:00 Audit. I Close Programme / The Breast 71S1 (2023) S9–S12 S12
Consensus Panellists Matti S. Aapro, CH Jyoti Bajpai, IN Carlos H. Barrios, BR Laura Biganzoli, IT Fatima Cardoso, PT Maria João Cardoso, PT Lisa A. Carey, US Mariana Chavez MacGregor, US Runcie C.W. Chidebe, NG Javier Cortés, ES Rebecca A. Dent, SG Nagi S. El Saghir, LB Alexandru Eniu, CH Lesley Fallowfield, UK Prudence A. Francis, AU Sandra Ximena Franco Millan, CO Karen Gelmon, CA Jenny Gilchrist, AU Joseph Gligorov, FR William J. Gradishar, US Nadia Harbeck, DE Xichun Hu, CN Ranjit Kaur, MY Belinda Kiely, AU Sung-Bae Kim, KR Marion Kuper-Hommel, NZ Frédéric E. Lecouvet, BE Ginny Mason, US Volkmar Mueller, DE Claire Myerson, UK Silvia Neciosup, PE Larry Norton, US Birgitte V. Offersen, DK Shinji Ohno, JP Shani Paluch-Shimon, IL Ann H. Partridge, US Frédérique Penault-Llorca, FR Hope S. Rugo, US Eva Schumacher-Wulf, DE Elzbieta Senkus, PL Sandra M. Swain, US Peter Vuylsteke, BW Eric P. Winer, US Theresa Wiseman, UK The Breast 71S1 (2023) S13 Contents lists available at ScienceDirect The Breast journal homepage: www.journals.elsevier.com/the-breast
Sponsored satellite symposia A Menarini Group Company Satellite symposium sponsored by Stemline. A Menarini Group Thursday 9 November 2023 – 18:00-19:30 Current and upcoming treatment strategies after CDK4/6 inhibitors for patients with ER+/HER2- advanced breast cancer 18:00-18:10 Welcome and introduction Ahmad Awada, BE 18:10-18:40 The current and future treatment landscape for ER+/HER2- mBC Ahmad Awada, BE 18:40-19:00 Emerging biomarkers in breast cancer: Implementing liquid biopsy ESR1 mutation testing Fredrik Marme, DE 19:00-19:10 Key takeaways Ahmad Awada, BE 19:10-19:30 Discussion All Symposium faculty Ahmad Awada, Jules Bordet Cancer Institute Brussels, BE Fredrik Marme, Uniklinik Mannheim, DE Satellite symposium sponsored by Daiichi Sankyo | AstraZeneca Friday 10 November 2023 - 18:00-19:30 Connecting the dots with antibody-drug conjugates (ADCs): Integrating patient experiences and recent data in metastatic breast cancer (mBC) 18:00-18:10 Welcome and introduction Sofia Braga, PT 18:10-18:25 Linking data with ADCs into clinical practice: How can we integrate recent data into the mBC treatment landscape? Barbara Pistilli, FR 18:25-18:40 Interpreting adverse events associated with ADCs: How can we optimise safety in mBC? Santiago Escrivá-de-Romaní, ES 18:40-18:55 Putting patients' quality of life first: What can we do to improve? Peter Fasching, DE 18:55-19:25 Panel discussion All faculty 19:25-19:30 Wrap up and close Sofia Braga, PT Symposium faculty Sofia Braga, Hospital Professor Doutor Fernando Fonseca, EPE, Amadora, PT Santiago Escrivá-de-Romaní, Breast Cancer and Melanoma Group, VHIO, Barcelona, ES Peter Fasching, Erlangen University Hospital, Erlangen, DE Barbara Pistilli, Gustave Roussy, Villejuif, FR The Breast 71S1 (2023) S14 Contents lists available at ScienceDirect The Breast journal homepage: www.journals.elsevier.com/the-breast 0960-9776/© 2023 Elsevier Ltd. All rights reserved.
Abstract Presenters Acharya Suryakanta, PAY-W Clinic, India Addai Abena, Breast Care International, Ghana Alevizopoulos Nektarios, Evaggelismos General Hospital, Greece Aliyeva Nigar, National Center of Oncology, Azerbaijan Ammendolea Cathy, Canadian Breast Cancer Network, Canada Avetisyan Artur, National Center of Oncology, Armenia Bashir Mariam, Lagos University Teaching Hospital, NSIA-LUTH Cancer Center, Nigeria Biganzoli Laura, Department of Medical Oncology, Hospital of Prato, Italy Boers-Doets Christine Bettine, CancerMed Side Effects Institute, Netherlands Bondar Maryna, National Cancer Institute, Ukraine Cardoso Maria João, Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation and Lisbon University Faculty of Medicine, Lisbon, Portugal Carey Lisa A., UNC-Lineberger Comprehensive Cancer Center, United States Chavez-MacGregor Mariana, Health Services Research, Breast Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, United States Chidebe Runcie C.W., Project PINK BLUE - Health & Psychological Trust Centre, Nigeria Cima Aljandra de, Fundación CIMA, Mexico Colomo Valeria, ONCOSALUD AUNA, Peru Cook Geoff, The Max Foundation, United States Cortés Javier, International Breast Cancer Center, Quironsalud Group, Barcelona; Medical Scientia Innovation Research, Barcelona; Faculty of Biomedical and Health Sciences, Department of Medicine, Universidad Europea de Madrid, Madrid, Spain DeCoteau MJ, Rethink Breast Cancer, Canada Dharsee Nazima, Ocean Road Cancer Institute, Tanzania Díaz Andrea Maliachi, Instituto Nacional de Cancerología, Mexico Drury Amanda, Dublin City University, Ireland Elhosary Mona, Patient Navigation Unit, Breast Comprehensive Cancer Center, National Cancer Institute, Cairo Univ., Egypt Eulade Rugengamanzi, Ocean Road Cancer Institute, Tanzania Fajar Rifaldy, Yogyakarta State University, Indonesia Fedorov Denys, State Institute «Shalimov's National Institute of Surgery and Transplantation» to National Academy of Medical Sciences of Ukraine, Ukraine Francis Prudence A., Peter MacCallum Cancer Centre, Melbourne, Australia Fujimoto Mutsumi, Department of Breast Surgery, Hiroshima University Hospital, Japan Gakii Gloria, Ongata Ngong Palliative Care Community, Kenya Gautier Adele, Breast Cancer Foundation NZ, New Zealand Gelmon Karen, BC Cancer Agency, Department of Medical Oncology, Vancouver, Canada Geus-Oei Lioe-Fee de, Department of Radiology, Leiden University Medical Center, Leiden. Biomedical Photonic Imaging Group, University of Twente, Enschede. Department of radiation Science & Technology, Technical University of Delft, The Netherlands Gligorov Joseph, Département d'Oncologie Médicale site hôpital Tenon, Institut Universitaire Cancérologie AP-HP Sorbonne Université Paris; Inserm U938 «Biologie et traitement des cancers», CRSA, Institut Universitaire de Cancérologie AP-HP Sorbonne Université Paris, France Gul Palwasha, Bolan Medical Complex Hospital, Quetta, Pakistan Gyawali Bishal, Department of Oncology, Queen's University, Kingston, Canada Haddaoui Seif, Abderrahmen Mami Hospital, Faculty of Medicine of Tunis; University Tunis Manar, Tunisia Han Chao, Guangzhou Anfang Bio-tech., China Harbeck Nadia, Breast Center, Dept. OB&GYN, and CCC Munich, LMU University Hospital, Munich, Germany Hu Xichun, Fudan University Cancer Hospital, Shanghai, China Jana Saptaparna, MAS Rural Initiative, India Jaramillo Juliana, Pfizer SAS, Colombia Javadinia Seyed Alireza, Sabzevar University of Medical Sciences, Iran Jenkins Valerie, SHORE-C Brighton & Sussex Medical School, University of Sussex, United Kingdom Kahharov Alisher, Tashkent State Dental Institute / Oncoschool by Djamila Polatova, Uzbekistan Kakharova Khilola, Khilola Kakharova, Tajikistan Kalogeropoulos Dimitrios, IEEE Standards Association Healthcare and Life Sciences Practice, New York, United States; Global Health & Digital Innovation Foundation, London; UCL Global Business School for Health, London, United Kingdom Kong Yek-Ching, Universiti Malaya, Malaysia Kozma Elvisa, University Hospital Mother Teresa, Albania Kuper-Hommel Marion, Te Whatu Ora Waikato, New Zealand Laakmann Elena, University Medical Center Hamburg-Eppendorf, Germany Lambertini Matteo, IRCCS Ospedale Policlinico San Martino, University of Genoa, Italy Laperashvili Nino, Todua Clinic /Association Hope, Georgia Larsson Karolina, Sahlgrenska University Hospital, Sweden Leach Virginia, United States Lecouvet Frédéric, Cliniques universitaires Saint-Luc and Institut du Cancer Roi Albert II, UCLouvain, Brussels, Belgium Lombardi Roberta, Infinite Strength, Inc., United States Mandal Nabanita, MAS Rural Initiative; Narikeldaha Prayas, India Manna Aditya, MAS Clinic & Hospital, India Maria Stancu Andra, Fundeni Clinical Institute, Romania Matos Leonor, Breast Unit, Champalimaud Clinical Centre / Champalimaud Foundation, Portugal Menon Manoj, Fred Hutchinson Cancer Center, United States Merschdorf Jennifer, Young Survival Coalition, United States Moukadem Hiba, American University of Beirut Medical Center, Lebanon Moulson Ruth, Pentavere, Canada Mouret-Reynier Marie-Ange, Centre Jean Perrin, France Nieto-Coronel Maria Teresa, Oncopalia Center, Bolivia Offersen Birgitte Vrou, Department of Experimental Clinical Oncology, Department of Oncology, Danish Center for Particle Therapy, Aarhus University Hospital, Denmark Olomu Ethel, Engraced Life Foundation, Nigeria The Breast 71S1 (2023) S15–S16 Contents lists available at ScienceDirect The Breast journal homepage: www.journals.elsevier.com/the-breast 0960-9776/© 2023 Elsevier Ltd. All rights reserved.
Omari Majid, Faculty of Sciences Dhar El Mahraz, Sidi Mohamed Ben Abdellah University, Fez, Morocco Onyedibe Maria-Chidi C., University of Nigeria Nsukka, Nigeria Pannell Allen, University of Tennessee, United States Partridge Ann, Dana-Farber Cancer Institute, Breast Oncology Dpt. and Adult Survivorship Programme, Boston, United States Pasca-Fenesan Mihaela-Maria, Oncohelp Oncology Center, University of Medicine and Pharmacy Victor Babes Timisoara, Romania Phillips Claire, Peter MacCallum Cancer Centre, Melbourne, Australia Planas-Silva Maricarmen, Angelmira's Center for Women with Advanced Cancer, United States Reyes Alexandra Garcilazo, Instituto Nacional de Cancerologia, Mexico Ritzén Hanna, Biovica, Sweden Sasada Shinsuke, Hiroshima University Hospital, Japan Sato Masako, KKR Sapporo Medical Center, Japan Savva-Bordalo Joana, IPO do Porto, Portugal Shockney Lillie, Johns Hopkins University School of Medicine, United States Sikand Jasmine, Rethink Breast Cancer, Canada Sivaram Rama, Sanjeevani Life beyond Cancer-NGO, India Smith Andrea, Daffodil Centre, University of Sydney, a joint venture with Cancer Council NSW, Australia Taleb Raghda Saad Zaghloul, Faculty of Medicine, Alexandria University, Egypt Tarasenko Tetiana, National Cancer Institute, Ukraine Tzintziropoulou Effrosyni, Hellenic association of women with breast cancer "ALMA ZOIS", Greece Valencia Guillermo, Instituto Nacional de Enfermedades Neoplásicas, Peru Vasileva-Slaveva Mariela, Bulgarian Breast and other gynecological Cancers Association, Bulgaria Vuylsteke Peter, University of Botswana, University of Botswana, Gaborone, Botswana Wang Biyun, Department of Breast and Urologic Medical Oncology, Fudan University Shanghai Cancer Center, China Watanabe Junichiro, Juntendo University, Japan Widera Karolina, III Department of Radiotherapy and Chemotherapy, National Institute of Oncology, Gliwice, Poland Wilcox Helena, The Health Policy Partnership, United Kingdom Winkler Sophie, LMU University Hospital, Germany Wiseman Theresa, The Royal Marsden NHS Foundation Trust, United Kingdom Würstlein Rachel, LMU University Hospital Munich, Breast Center and CCC Munich, LMU Munich, Germany Yamout Rana, American University of Beirut Medical Center, Lebanon Young Leonie, Reach to Recovery International, Australia Zambon Marzia, EUROPA DONNA - The European Breast Cancer Coalition, Italy Abstract Presenters / The Breast 71S1 (2023) S15–S16 S16
RkJQdWJsaXNoZXIy MTk3NTQxMg==